Vivos Therapeutics Inc.
VVOS | NASDAQ
$0.50
-$0.01 (-2.19%)
Jun 18, 2026, 4:00 PM ET · Market open
Market Data
Market Cap $3.21M
Enterprise Value $12.68M
Beta 6.08
Average Volume 227.35K
Shares Outstanding (Diluted) 14.63M
Shares Change YoY 70.26%
Institutional Ownership 6.00%
Exchange NASDAQ
ISIN US92859E2072
Price Performance
Price Change 1M -19.4%
Price Change 3M -59.0%
Price Change 6M -75.6%
Price Change YTD -80.2%
Price Change 1Y -79.8%
Price Change 3Y -95.9%
Price Change 5Y -99.6%
1M CAGR (ann.) -27.9%
1Y CAGR (ann.) -77.1%
5Y CAGR (ann.) -67.8%
All-Time CAGR -66.8%
Valuation
PE Ratio -0.22
Forward PE N/A
PEG Ratio 0.02
Forward PEG N/A
PS Ratio 0.15
Forward PS 0.10
PB Ratio -2.59
P/FCF Ratio -0.16
P/Adj. FCF Ratio -0.16
P/OCF Ratio -0.42
EV/Sales 0.65
EV/EBIT -0.79
EV/EBITDA -0.57
EV/FCF -0.70
Earnings Yield -460.0%
FCF Yield -619.7%
Adj. FCF Yield -636.5%
Financial Health
Net Debt $9.74M
Total Debt $11.85M
Cash & Short-Term Investments $2.11M
Total Assets $25.04M
Current Ratio 0.27
Quick Ratio 0.27
Debt / Equity Ratio -10.78
Debt / EBITDA -0.54
Debt / FCF -0.65
OCF / Debt -1.47
Interest Coverage 0.00
Altman Z-Score -9.32
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 59.5%
Operating Profit Margin -113.2%
EBITDA Margin -120.3%
Net Profit Margin -128.4%
FCF Margin -93.3%
Adj. FCF Margin -95.8%
SBC / Revenue 2.5%
SBC Impact (per share) -2.7%
Returns
Return on Assets -100.3%
Return on Equity -2239.2%
Return on Invested Capital -148.6%
Return on Capital Employed -318.0%
Return on Tangible Assets -198.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 2.9%
Revenue CAGR 5Y 6.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 30.7%
EPS CAGR 5Y 18.3%
EPS CAGR 10Y N/A
FCF CAGR 3Y 4.7%
FCF CAGR 5Y -40.7%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Aug 17, 2026
EPS Estimate (next Q) -$0.42
EPS Growth Est (next Q) -23.6%
Revenue Est (next Q) $5.57M
Revenue Growth Est (next Q) 45.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $2.13
Price Target Upside 326.0%
Cash Flow
Operating Cash Flow $-17.48M
Free Cash Flow $-18.25M
Adj. Free Cash Flow $-18.74M
FCF Per Share -$1.25
OCF Per Share -$1.19
OCF/S Ratio -89.3%
Income Statement
Revenue $19.57M
Gross Profit $12.09M
Operating Income $-22.14M
EBITDA $-22.15M
Net Income $-25.05M
EPS (Diluted) -$2.30
Revenue / Employee $179.52K
Profit / Employee $-229.81K
Employees 109
Add to Watchlist
Select watchlists to add or remove VVOS